Photodynamic therapy of psoriasis

Bibliography:
1. Tappeiner H. Ueber die Wirkung fluorescierende Stoffe auf Infusiorien nach Versuhen von Raab O. Munch Med Wochenschr 1900; 47: 5
2. Raab O. Ueber die Wirkung fluorescierende Stoffe auf Infusiorien. Z Biol 1900; 39: 524-546
3. Tappeiner H, Jesionek H. Therapeutische versuche mit fluoreszierenden stoffen. Munch Med Wochenschr 1903; 47: 2042-2044
4. Tappeiner, H, Jodlbauer A. Die sensibilisierende wirkung fluorescierender substanzen: Gesammelte untersuchungen uber die photodynamische erscheinung. F. О W 1907
5. Triesscheijna M, Baas PP, Schellensa J. Photodynamic therapy in oncology. Oncologist 2006; 11: 1034-1044
6. Hausmann W. Die sensibilisierende wirkung des ham-atoporphyrins. Biochem Z 1910; 30: 276-316
7. Hausmann W Die sensibilisierende Wrkung des Ham-atoporphyrins. Biochem Z 1911; 30: 276-316
8. Meyer-Betz F. Untersuchung uber die biologische (photodynamische) wirkung des hamatoporphyrins und anderer deri-vate des blutund gallenfarbstoffs. Dtsch Arch Klin Med 1913; 112: 476-503
9. Hamblin MR, Huang YY. Handbook of photomedicine. CRC Press 2014: 815
10. Wan MT, Lin JY Current evidence and applications of photodynamic therapy in dermatology. Clinical, Cosmetic and In-vestigational Dermatology 2014; 7: 145-163. 11. Choi YM, Adelzadeh L, Wu JJ. Photodynamic therapy for psoriasis. J Dermatolog Treat, Early Online: 1-6
12. Hong JS, Jung JY, Yoon JY, Suh DH. Acne treatment by methyl aminolevulinate photodynamic therapy with red light vs intense pulsed light. Int J Dermatol 2013; 52 (5): 614-619
13. Clark C, Bryden A, Dawe R, et al. Topical 5-amino-laevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoim-munol Photomed 2003; 19 (3): 134-41
14. Gholam P, Kroehl V, EnkAH. Dermatology life quality index and side effects after topical photodynamic therapy of actinic keratosis. Dermatology 2013; 226 (3): 253-259
15. Orenstein A, Kostenich G, Tsur H, et al. Temperature monitoring during photodynamic therapy of skin tumors with topical 5-ami-nolevulinic acid application. Cancer Lett 1995; 93 (2): 227-232
16. Carrion-Gutierrez M, Ramirez-Bosca A, Navarro-Lo-pez V, et al. Effects of Curcuma extract and visible light on adults with plaque psoriasis. Eur J Dermatol 2015; 25 (3): 240-6
17. Jin Y, Zhang X, Zhang B, et al. Nanostructures of an amphiphilic zinc phthalocyanine polymerconjugate for photodynamic therapy of psoriasis. Colloids and Surfaces B: Biointerfac-es2015; 128:405-409
18. Cunha JS, Amorese-O'Connell L, Gutierrez M, et al. Ultrasound imaging of nails in psoriasis and psoriatic arthritis. Curr Treat Options in Rheum 2017; 3: 129-140
19. Pradhan M, Singh D, Singh MR. Novel colloidal carriers for psoriasis: Current issues, mechanistic insight and novel delivery approaches. Journal of Controlled Release 2013; 170 (3): 380-395
20. MenterA, Gottlieb A, Feldman SR. Guidelines of care for the management of psoriasis and psoriatic arthritis. J Am Acad Dermatol 2008; 58 (5): 826-850
21. Stringer MR, Collins P, Robinson DJ. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Iwest Dermatol 1996; 107: 76-81
22. Silver H. Psoriasis vulgaris treated with haemotopor-phyrin. Arch Dermatol Syphilol 1937; 36: 1118-1119
23. Sharman WM, Allen CM, van Lier JE. Photodynamic therapeutics: basic principles and clinical applications. DDT 1999; 4 (11): 507-517
24. Richard EG, Hbnigsmann H. Phototherapy, psoriasis, and the age of biologies. Photodermatol, Photoimmunol & Pho-tomed 2014; 30(1): 3-7
25. Lee Y, Baron ED. Photodynamic therapy: current evidence and applications in dermatology. Semin Cutan Med Surg 2011; 30: 199-209
26. Collins P, Robinson DJ, Stringer MR, et al. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 137:743-9
27. Robinson DJ, Collins P, Stringer MR, et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Ve-nereol 1999;79:451-5
28. Beattie PE, Dawe RS, Ferguson J et al. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clin Exp Dermatol 2004; 29: 560-2
29. Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, et al. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol 2005; 152: 279-83
30. Smits T, Kleinpenning MM, van Erp PEJ, et al. A place-bocontrolled randomized study on the clinical effectiveness, im-munohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis. Br J Dermatol 2006; 155: 429-36
31. Kleinpenning MM, Kanis JH, Smits T, et al. The effects of keratolytic pretreatment prior to fluorescence diagnosis and photodynamic therapy with aminolevulinic acid-induced porphy-rins in psoriasis. J Dermatolog Treat 2010; 21: 245-51
32. Maytin EV, Honari G, Khachemoune A, et al. Vitamin D combined with aminolevulinate (ALA) — mediated photodynamic therapy (PDT) for human psoriasis: a proof-of-principle study. Isr JChem 2012; 52: 767-75
33. Bissonnette R, Tremblay JF, Juzenas P, et al. Systemic photodynamic therapy with aminolevulinic acid induced apopto-sis in lesional T-lymphocytes of psoriatic plaques. J Invest Dermatol 2002; 119:77-83.